NHS research and development (R&D) gets £27 million boost:
This article was originally published in Clinica
Executive Summary
The NHS Research and Development Strategy has been singled out by UK Health Secretary Stephen Dorrell to receive extra funds in 1996/7. The project's budget will be increased by £27 million ($42 million) to £436 million to "ensure that R&D prospers alongside patient care, enabling better healthcare solutions to be widely disseminated and implemented", says Mr Dorrell. Among special allocations to the new Health Authorities (which will be established in April next year) is £270 million for AIDS projects.
You may also be interested in...
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.
Normality Reasserts Itself For Biotech IPOs
The highs of the COVID-19 era, and the lows that supplanted it, are beginning to fade.
Executives On The Move: Changes At The Top At Viatris And Clinuvel Among This Week's Announcements
Recent moves in the industry include C-suite shuffle at Brainstorm Cell Therapeutics and new CFOs at Faron Pharmaceuticals and Foghorn Therapeutics, among others.